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Objective: To compare the level of glutathione (GSH) and oxidized glutathione (GSSG),
the ratio of GSH/GSSG and the concentration of albumin in plasma of patients with
complicated and un-complicated falciparum malaria.
Methods: This research was a cross sectional study using comparison analysis with the
plasma GSH and GSSG, the ratio of plasma GSH/GSSG and the concentration of plasma
albumin as variables. The complicated malaria patients were obtained from Dr. Saiful
Anwar Hospital Malang, whereas uncomplicated malaria patients were obtained from the
Regency of Pleihari South Kalimantan. Plasma GSH and GSSG levels were determined
by the spectrophotometer at the wave length of 412 nm, whereas the concentration of
albumin was determined by bromocresol green method in the pH of 4.1.
Results: There were no signiﬁcant differences between the level of plasmaGSH andGSSG
in complicated and uncomplicated malaria patients, as well as the ratio of plasma GSH/
GSSG in the two groups (P = 0.373; P = 0.538; and P = 0.615, respectively, independent t-
test). In contrast, the plasma albumin concentration in complicated malaria patients were
signiﬁcantly higher than uncomplicated malaria patients (P = 0.000, MannWhitneyU test).
Conclusions: It can be concluded that the average of plasma GSH and GSSG level, also
plasma GSH/GSSG ratio in complicated malaria are not different from uncomplicated ma-
laria. Although plasma concentration of albumin in both groups is below the normal range,
there is an increase in complicatedmalaria that might be as compensation of oxidative stress.1. Introduction
The main sources of oxidant during malaria infection are
from hemoglobin digestion in the food vacuole of parasite insidehost erythrocyte, the synthesis and folding of proteins within the
endoplasmic reticulum, as well as the production of the energy
(adenosine triphosphate) in the mitochondria. However, para-
sites maintain the redox equilibrium using antioxidant systems
[1]. Oxidative stress can be regarded as an imbalance between
oxidant production and antioxidant defenses. Overproduction
of oxidant or reactive oxygen species can be toxic to cells
causing oxidation of macromolecules, including lipids, protein
and nucleic acids followed by cellular and tissue damage [2].
Glutathione (GSH) is the most abundant antioxidant in all
aerobic cells, presenting with high-concentrations in body ﬂuids
and tissue. GSH which is synthesized from L-glutamate, L-
cysteine and L-glycine is critical for protecting the tissue from
oxidative stress, acting as a free radical scavenger and inhibitorarticle under the CC BY-NC-ND license (http://
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by GSH using enzymatic reduction, whereas the elimination of
H2O2 requires enzymatic catalysis by GSH peroxidase and
catalase. During this process GSH becomes oxidized
glutathione (GSSG). This GSSG characterized by a disulﬁde
bond between two molecules of GSH is efﬁciently reduced
back to GSH by the nicotinamide adenine dinucleotide
phosphate (NADPH)-dependent catalysis of the ﬂavoenzyme
GSH reductase [4].
When a strong oxidative stress is exposed to mammalian
cells, this condition may require not only enhanced GSH action
to maintain redox status, but also augmented energy supply and
precursors to enhance GSH content and transport it to the places
where it is needed. Moreover, when oxidative stress becomes
prolonged and cellular systems are no more able to counteract
the abundant of oxidative stress, the ratio of GSH/GSSG will
reduce as a consequence of decreased amount of free GSH [4].
The ratio of reduced GSH to GSSG can be used as an
indicator of cellular health. Measuring the ratio of GSH/GSSG
in pathological tissues and experimental models compared to
those in normal tissues is an excellent procedure to know the
efﬁcacy of antioxidant therapeutics in maintaining cellular
redox [3].
The invasion of malaria parasite in human erythrocytes
causes a potential oxidant that will induce the antioxidant
resistance of erythrocytes [5]. The GSH metabolism of the
parasites is regulated by its biosynthesis, reduction and efﬂux.
GSH biosynthesis in Plasmodium falciparum is related to the
rapid efﬂux of GSH from the infected erythrocytes and the
parasite's inability to scavenge sufﬁcient amounts of the
tripeptide from its environment to compensate that efﬂux [6].
GSH efﬂux from Plasmodium falciparum infected erythrocytes
is actually greater than that from uninfected erythrocytes [7].
Albumin, a non-glycosylated, negatively charged plasma
protein, with ascribed ligand-binding normally accounts for over
50% of total plasma protein content. Albumin is present as
transport protein and serves multifunctional activities like anti-
oxidant functions, and enzymatic activities. Albumin could
potentially reduce oxidant effects through scavenging antioxi-
dant actions, modifying redox balance, and regulating cell
signaling moieties active in mediating pro-inﬂammatory
response [8,9]. A previous study has shown that albumin
resuscitation may reduce mortality rate in children with severe
malaria. Mortality decreased in children receiving albumin
than in those treated with gelofusine (Fisher's exact test,
P = 0.06). The effect of albumin on mortality showed a
pooled relative risk of death with albumin administration of
0.19 (95% CI: 0.06–0.59; P = 0.004) compared to other ﬂuid
boluses [10].
Based on the above facts and theories, this study will
compare GSH and GSSG level, GSH/GSSG ratio and albumin
concentration in plasma between complicated and uncompli-
cated falciparum malaria.
2. Materials and methods
2.1. Sample collection
This study was a cross sectional study with descriptive
analysis data to determine the level of GSH, GSSG and the ratio
of GSH/GSSG and the level of albumin in the plasma of malaria
patients. This research was conducted at the Central Laboratoryof Biomedical, Faculty of Medicine Universitas Brawijaya and
the Central Laboratory of Dr. Saiful Anwar Hospital Malang.
The experiment was conducted from November 2009 to April
2010. Ethical clearance was provided on 16 November 2009 by
the committees of research of the Faculty of Medicine, Uni-
versitas Brawijaya.
The research subject was blood plasma of complicated ma-
laria falciparum patients (n = 9) from Dr. Saiful Anwar Hospital
Malang (most of them were imported cases from Kalimantan
island) and uncomplicated malaria falciparum patients (n = 10)
from the district of South Kalimantan, Pleihari. Blood was taken
with the informed consent. All blood chemical parameters [urea,
creatinine, serum glutamic-oxaloacetic transaminase (SGOT),
serum glutamic pyruvic transaminase (SGPT) and bilirubin
level] were determined in Central Laboratory of Dr. Saiful
Anwar Hospital Malang.
Reduced GSH and GSSG level were detected using the Oxis
kit/Research TM. Catalog number 21040. The level of the di-
sulﬁde GSSG formed consisting of two molecules of GSH
through a combination of the reaction between GSH and 5,50-
dithio-bis (2-nitrobenzoic acid) to form 5-thio-2-nitrobenzoic
acid and GS-5-thio-2-nitrobenzoic acid (glutathione adduct of
GSH), which immediately reduced to GSH. The ratio of GSH/
GSSG was then counted by dividing the difference level be-
tween the GSHt and GSSG (reduced GSH) by the level of GSSG
or (GSHt−2 GSSG)/GSSG. Albumin concentration in plasma
was measured by bromocresol green method in Roche/Hitachi
Cobas c 501-analyzer.
2.2. Preparing GSH samples
Fifty microliters of blood plasma was inserted into the base
of microcentrifuge tube then frozen at −70 C. In the experiment
day, samples were thawed and immediately mixed. A total of
350 mL of 5% metha phosporic acid (MPA) was inserted into the
tube (dilution 1/8 of the original sample). Samples were vor-
texed for 15–20 s and then centrifuged at 3500 r/min for 10 min.
Then 50 mL of MPA extract was added to 3 mL of assay buffer
(1/61 dilution acid supernatant). Supernatant was placed in a
cooler for measuring in spectrophotometer.
2.3. Preparing GSSG samples
Ten microliters of 1-methyl-2-vinyl trivate pyridium were put
into the tube then 100 mL blood plasma was carefully inserted to
the bottom of centrifuge tube. The tube was mixed gently. The
samples were frozen at −70 C. In the experiment day samples
were thawed then incubated at room temperature for 2–10 min. A
total of 290 mL of 5% MPA was inserted into a chilled tube con-
taining the samples (1/4 dilution of the original sample). Samples
were vortexed for 15–20 s and centrifuged at 3500 r/min speed for
10 min. Then 50 mL MPA extract was added to 700 mL of GSSG
buffer (1/5 dilution acid supernatant). Supernatant was placed in a
cooler for measuring in spectrophotometry (dilute 1/60).
2.4. Determination of levels of GSH, GSSG, and the
ratio of GSH/GSSG
A total of 200 mL of standards and samples were added to the
cuvettes. Then 200 mL of chromogen was added to each cuvette,
and 200 mL of the enzyme was added to each cuvette, mixed and
then incubated at room temperature for 5 min. A total of 200 mL
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412 nm for 3 min were recorded and observed.
2.5. Data analysis
The statistical analysis was conducted using the independent
t-test (P < 0.05). Checking distribution of data was performed
by Shapiro–Wilk test due to normal distribution of data then
unpaired t-test was held.
3. Results3.1. Samples characteristic
Characteristics of malaria patients used in this study are
presented in Table 1. There were some differences in the char-
acteristics of laboratory values between the plasma ofTable 1
Characteristics of complicated and uncomplicated malaria patients.
Indicator Complicated
malaria
Uncomplicated
malaria
P
value
Age (year) 45 ± 13 41 ± 13 0.77***
Sex (males/
females)
8/2 9/0 0.81***
Parasitemia (‰) 32.17 ± 13.47 2.80 ± 1.55 0.00*
Urea (mg/dL) 65.93 ± 73.42 13.57 ± 5.55 0.03*
Creatinine (mg/
dL)
1.24 ± 1.99 0.10 ± 0.09 0.08*
SGOT (IU/L) 28.11 ± 23.05 8.80 ± 2.27 0.01*
SGPT (IU/L) 9.22 ± 14.33 0.50 ± 1.20 0.01**
Total bilirubin
(mg/dL)
2.25 ± 4.74 0.10 ± 0.11 0.17*
Bilirubin direct
(mg/dL)
1.55 ± 3.35 0.06 ± 0.06 0.17*
Bilirubin direct
(mg/dL)
0.69 ± 1.40 0.06 ± 0.06 0.17*
*: Independent t-test; **: Mann Witney U test; ***: Fisher's exact test; The
values were expressed as mean ± SD.
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Figure 1. Average GSH level (A), average GSSG level (B), GSH/GSSG ratio (C
(n = 9) and uncomplicated malaria patients (n = 10).
Similar notation showed there was no signiﬁcant difference.complicated malaria patients and that of uncomplicated malaria
patients. Statistical analysis showed that the average concen-
tration of urea, SGOT, SGPT and the degree of parasitemia of
complicated malaria patients and uncomplicated malaria's
plasma patients used in this study have signiﬁcant differences
(P = 0.03; P = 0.01; P = 0.01; P = 0.00).3.2. GSH level in plasma patients of complicated and
uncomplicated malaria
The average level of GSH in patients with complicated malaria
was (81.67 ± 3.68) mmol/L, while in uncomplicated malaria pa-
tients, was (80.40 ± 1.80) mmol/L (Figure 1A). It was found that
the average level of GSH in patients with complicated malaria
was higher than those in patients with uncomplicated malaria,
however, based on independent t-test it is known that the differ-
ence in average levels of plasma GSH of patients with compli-
cated and uncomplicated malaria was not signiﬁcant (P = 0.373).
3.3. GSSG level in plasma patients of complicated and
uncomplicated malaria
GSSG level was obtained through the spectrophotometry
method. The average level of GSSG in complicated malaria was
higher than that of uncomplicated malaria i.e. (495.48 ± 98.80)
mmol/L in complicated malaria compared to (474.54 ± 6.73)
mmol/L in uncomplicated malaria patients (Figure 1B). Statisti-
cal analysis using independent t-test showed no signiﬁcant dif-
ference (P = 0.536) on average of plasma GSH level between
two groups (Figure 1A). Similar result was found on average
plasma GSSG level (Figure 1B).
3.4. GSH/GSSG ratio in plasma patients of complicated
and uncomplicated malaria
The average ratio of GSH/GSSG in the group of patients with
complicated malaria was higher (4.29 ± 1.40) compared to those3.0
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yield no signiﬁcant difference (P = 0.615) on average of GSH/
GSSG ratio between two groups (Figure 1C).3.5. Albumin concentration in plasma patients of
complicated and uncomplicated malaria
Plasma albumin levels showed to be below the normal range
in both groups. However, the average albumin concentration in
complicated malaria patients was higher (2.14 ± 1.17) g/dL
compared to those in uncomplicated malaria patients
(1.34 ± 0.45) g/dL as shown in Figure 1D. Statistical analysis
using Mann–Whitney U test showed a signiﬁcant difference
(P = 0.000) on average concentration of plasma albumin be-
tween groups.4. Discussion
A potential source of free radical production in malarial
disease is from hemoglobin degradation which done by para-
sites, resulting in the liberation of large amounts of circulating
heme. Another source is from activated macrophages and neu-
trophils which generate large amounts of reactive oxygen spe-
cies and reactive nitrogene species, causing an imbalance
between the formation of oxidizing species and the activity of
antioxidants. This imbalance triggers alterations in redox status,
which is an important mechanism of human hosts in response to
malaria infection [11].
Oxidative stress induced by inﬂammatory process during
falciparum malaria infection leads to increase lipid peroxidation
due to an imbalance between plasma oxidant and antioxidant
system [12]. This inﬂammatory process that mediated by effector
immune response mechanisms is required to eliminate malaria
parasite. However, these mechanisms are not sufﬁcient and to
some extent, may further harm the host cell. These
mechanisms lead to the decrease of the antioxidant capacity,
therefore, reﬂecting the severity of the disease [11]. Sibmooh
et al. reported that during malaria infection, the lipoproteins
are oxidatively modiﬁed, and the degree of oxidation is related
to the severity of the disease. These oxidized lipids may have
a role in pathomechanism of complicated malaria by
increasing the endothelial expression of adhesion molecules
[13]. Previous study reported that oxidative stress and
antioxidant defense system were also altered in cerebral
malaria. Some parameters such as reduced GSH, catalase,
malondialdehyde, triglycerides and very low-density lipopro-
tein cholesterol were increased signiﬁcantly in cerebral malaria
patients compared to that of control [14].
The antioxidant level may be a useful marker of oxidative
stress during malaria infection [15]. In this study, the average of
GSH level on plasma of complicated and uncomplicated malaria
patients showed no signiﬁcant difference. The explanation is that
high oxidative stress will stimulate the body to achieve a new
balance. GSH is moderately stable in the intracellular
environment because intracellular peptidases can cleave
peptide bonds formed by the a-carboxyl groups of amino
acids. The steady-state level of intra-cellular and the extracel-
lular of GSH are provided by the balance between production
and consumption, as well as by extrusion from the cell as
reduced, oxidized, or bound forms [16]. GSH is oxidized through
antioxidant reactions by an active glutathione reductase redoxcycle. Efﬂux, detoxiﬁcation and antioxidant reactions led to a
constant loss of GSH, is compensated by active GSH
biosynthesis [17].
Even though the statistical test of independent t-test showed
no signiﬁcant difference in the average level of GSSG, these
results indicated that the higher the severity of malaria disease,
the higher the levels of GSSG in plasma. In a study by Barrand
et al. there was no export of GSSG detected under physiological
conditions from uninfected/unchallenged cells, in contrasts with
the situation in infected cells in which there were GSSG export
under adenosine triphosphate-depleting conditions. The
increasing of GSSG levels inside isolated parasites using
200 mmol/L diamide produced no change in the total GSH
content, but it reduced the total efﬂux [7]. Both GSH and GSSG
are circulated and are used to supply other organs. The
circulation is related to GSH functions, and at least two
principles may be implicated. The main GSH function is
directed to detoxiﬁcation of injurious external agents to
prevent damage to the vital organ. The second function is
related to high intensity oxygen-based metabolism and detoxi-
ﬁcation of certain compounds by internal organs. The problems
with extracellular and systemic GSH are related with the con-
centrations of extracellular GSH which are in a large extend
higher than intracellular levels, thus correct redox ratios are
often difﬁcult to determine [16].
GSH/GSSG ratio also showed no signiﬁcant difference be-
tween complicated and uncomplicated malaria patients. To
maintain redox homeostasis, aerobes are completed with
enzymatic and nonenzymatic antioxidants. Two central thiol/
disulﬁde couples are involved in controlling the redox state of
the cells, there are GSH/GSSG and dithiol/disulﬁde of thio-
redoxins (Trxred/Trxox). GSH/GSSG is the major redox couple
that determines the antioxidative capacity of cells [18,19]. GSH/
GSSG homeostasis involves intra- and extracellular
mechanisms. GSH is synthesized from amino acids by the
action of g-glutamylcysteine synthetase and GSH synthase.
The GSH conjugates and GSSG are transported out of the
cell via GS–X/GSSG pumps. The NADPH-dependent GSH
reductase is responsible for the intracellular recycling of GSH,
while extracellular GSH gets sequentially hydrolyzed by
g-glutamyl transpeptidase and dipeptidase, with glutamate,
cysteine and glycine being recycled for GSH synthesis
(g-glutamyl cycle) [19].
This study showed that the higher level of plasma albumin in
complicated malaria patients might be a compensation effect of
oxidative stress. This contrasts with the previous study by Sib-
mooh et al. where the concentration of albumin in non-
complicated malaria, was higher than those in complicated
malaria [13]. However, Abdagalil and ElBagir reported that the
albumin fraction levels similar in both lightly infected patients
and heavily-infected patients [20]. Another study remains
unexplained why 40% children which were conﬁrmed to be
suffering from Plasmodium infection had the plasma albumin
levels above normal [21].
Albumin is a complex molecule which acts as the main
transporter of plasma fatty acids. Vascular endothelial cells ex-
press speciﬁc binding sites for albumin which may assist in its
ability to prevent endothelial cell apoptosis, an important
mechanism of malaria complication. Albumin regulates pyruvate
dehydrogenase enzyme in astrocytes and thus helps in efﬂux of
glucose and lactate that can inﬂuence the microenvironment.
Albumin infusion in severe malaria increase the formation of
Loeki Enggar Fitri et al./Asian Pac J Trop Biomed 2016; 6(8): 646–650650lipoxins and 10,17S-dihydroxydocosatriene or neuroprotectin
D1 a bioactive mediators derived from docosahexaenoic acid
(DHA). This substance causes the mobilization of DHA pro-
duced neuroprotection [22,23]. Undurti showed that intravenous
albumin administration is useful in critical care on those
because of medical conditions, surgery, and sepsis.
Cytoprotective action of albumin is due to increased formation
protectin of DHA and polyunsaturated fatty acids [23].
It can be concluded that the average concentration of GSH
and GSSG, GSH/GSSG ratio, in plasma patients with compli-
cated malaria are not different from that of uncomplicated ma-
laria. Plasma albumin levels showed to be low in both groups.
The higher plasma concentration of albumin in complicated
malaria might be a compensation response. Further study with
larger sample size is needed to draw a deﬁnite conclusion. The
needs of albumin as antioxidants could be a consideration in the
management of nutritional therapy to accelerate the healing
process during malaria infection.
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